Detail
LncRNA Name | AC156455.1 |
Synonyms | AC156455.1, LOC100506691 |
Region | GRCh38_12:122063306-122068616 Sequence |
Ensembl | ENSG00000256546 |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | childhood acute lymphoblastic leukemia |
ICD-0-3 | M9835/3 |
Methods | qPCR etc. |
Sample | cell lines (Reh, NALM-6) |
Expression Pattern | up-regulated |
Function Description | We validated that five such lncRNA transcripts overexpressed in pre-B cALL samples (RP11-137H2.4, RP11-68I18.10, AC156455.1, KB-208E9.1, and CTA-331P3.1) were also overexpressed in the Reh and NALM-6 pre-B cALL cell lines that had significant impacts on cancer hallmark traits such as cell proliferation, migration, apoptosis, and treatment response. |
Pubmed ID | 27980230 |
Year | 2017 |
Title | A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration. |
External Links |
Links for AC156455.1 | GenBank HGNC lncrnadb Noncode |
Links for childhood acute lymphoblastic leukemia | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.